Japanese Firm Slammed for Falsifying Certificates of Analysis

Drug Industry Daily
A A
Japanese drugmaker Daito Kasei Kogyo was hit with a warning letter by the FDA for having inadequate testing procedures and falsifying certificates of analysis issued to customers from its facility in Bizen, Okayama.

To View This Article:

Login

Subscribe To Drug Industry Daily